WIPO trademark

PROGRAM CANCER AGAINST ITSELF

MixedWIPOClass 5Class 44

"PROGRAM CANCER AGAINST ITSELF" is a trademark owned by Earli Inc., filed at the WIPO on July 15, 2026. It is on file and covers classes 5 and 44.

View Earli Inc. portfolioGet this data via the API
PROGRAM CANCER AGAINST ITSELF
Trademark as filed with the WIPO
Status
Mixed
Filed
July 15, 2026
Registered
Not yet
Expires
July 15, 2036
Application no.
Not recorded
Registration no.
1938876
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns PROGRAM CANCER AGAINST ITSELF

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Earli Inc.

8 trademarks in the portfolioView company

Representative

Ted D. Karr Berkeley Law & Technology Group LLP

Ted D. Karr Berkeley Law & Technology Group LLP

Goods and services

What the mark covers

The products and services PROGRAM CANCER AGAINST ITSELF is filed for, grouped by Nice class.

  • Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer.

  • Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer.

FAQ

About PROGRAM CANCER AGAINST ITSELF

Who owns the trademark "PROGRAM CANCER AGAINST ITSELF"?

The WIPO trademark "PROGRAM CANCER AGAINST ITSELF" is owned by Earli Inc.

What is the status of "PROGRAM CANCER AGAINST ITSELF"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PROGRAM CANCER AGAINST ITSELF and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_a2b64c98-a567-40c5-8fe4-b19b8d46a32a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_a2b64c98-a567-40c5-8fe4-b19b8d46a32a",
  "object": "trademark",
  "mark_text": "PROGRAM CANCER AGAINST ITSELF",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2026-07-15",
  "nice_classes": [
    5,
    44
  ],
  "owners": [
    {
      "name": "Earli Inc.",
      "entity_id": "ent_019ebbc3-2f10-745b-b5e9-7c2632a63ad7"
    }
  ]
}